These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 37511235)

  • 21. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
    Thakur P; Nehru B
    Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
    Çınar E; Tel BC; Şahin G
    Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tannic Acid Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Inflammation, Oxidative Stress, Apoptosis, and Glutamate Toxicity in Rats.
    Azimullah S; Meeran MFN; Ayoob K; Arunachalam S; Ojha S; Beiram R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.
    Chetia Phukan B; Dutta A; Deb S; Saikia R; Mazumder MK; Paul R; Bhattacharya P; Sandhir R; Borah A
    Exp Brain Res; 2022 Jan; 240(1):113-122. PubMed ID: 34633467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
    Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
    Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
    Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.
    Dutta A; Phukan BC; Roy R; Mazumder MK; Paul R; Choudhury A; Kumar D; Bhattacharya P; Nath J; Kumar S; Borah A
    Metab Brain Dis; 2022 Aug; 37(6):1887-1900. PubMed ID: 35622265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
    Mishra AK; Dixit A
    Neurochem Res; 2022 Feb; 47(2):234-248. PubMed ID: 34637100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death.
    Zhang W; Zecca L; Wilson B; Ren HW; Wang YJ; Wang XM; Hong JS
    Front Biosci (Elite Ed); 2013 Jan; 5(1):1-11. PubMed ID: 23276965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease.
    Al-Nusaif M; Lin Y; Li T; Cheng C; Le W
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferroptosis and cell death mechanisms in Parkinson's disease.
    Guiney SJ; Adlard PA; Bush AI; Finkelstein DI; Ayton S
    Neurochem Int; 2017 Mar; 104():34-48. PubMed ID: 28082232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
    Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
    Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
    Marchetti B; Giachino C; Tirolo C; Serapide MF
    Aging Cell; 2022 Apr; 21(4):e13575. PubMed ID: 35262262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.